Download Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Mucosal Atomization Devices Market By Type, By End User and Region Forecast 2020-2031
Mucosal Atomization Devices Market By Type, By End User and Region Forecast 2020-2031
Mucosal Atomization Devices Market size was valued at US$ 833.4 million in 2024 and is expected to reach US$ 1,391.6 million by 2031, growing at a significant CAGR of 7.6% from 2025-2031. Due to the accelerating research and development in the field, more clinical data demonstrating the advantages of mucosal atomization devices are emerging. Mucosal atomization devices are mostly used for drug delivery through nasal mucosa for treating chronic diseases such as allergic rhinitis and sinusitis. The nasal route is being chosen increasingly by the medical sector as it permits rapid absorption of therapeutics and offers higher efficiency.
The market is on the rise as it offers a very effective substitute to the traditional needle-based injection drug delivery technique. The affordability of mucosal atomization devices has significantly assisted in the growth of this market. These devices are innovative, reliable, and highly efficient for drug administration and are continuously becoming popular in the healthcare sector. As a result, the market for musical atomization devices is given a chance to expand due to the growing acceptance of this. Additionally, the market is anticipated to rise as more healthcare facilities start to offer innovative, easier, and effective drug delivery techniques.
Study Period
2025-2031Base Year
2024CAGR
7.6%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Fast delivery of the medication is a key driving factor for the growth of the market. Correspondingly, due to its non-invasive nature, drug administration is also relatively easy. Such advantages have helped in driving the acceptance of mucosal atomization devices and boosting the expansion of the market. Furthermore, the affordability of these devices has considerably helped in the growth of their market. However, market for mucosal atomization devices will hamper with the delayed launch of innovative advanced medical devices.
The mucosal atomization devices market in North America is expected to account for leading revenue shares in mucosal atomization devices in the upcoming future, predominantly attributed to the technological advancements in the field of healthcare. The United States is the industry's center with the most drug delivery research facilities worldwide. Like developed nations, there is also an increasing need for technologically advanced devices in emerging countries for quicker delivery and better bioavailability for drug administration, which will undoubtedly spur the market's expansion throughout the projected period.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2025-2031 |
|
Market Size in 2024 |
US$ 833.4 million |
|
Market Size in 2031 |
US$ 1,391.6 million |
|
Market CAGR |
7.6% |
|
By Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The mucosal atomization devices market size was valued at US$ 833.4 million in 2024 and is expected to reach US$ 1,391.6 million by 2031, growing at a significant CAGR of 7.6% from 2025-2031.
Teleflex Incorporated, DeVilbiss Healthcare LLC, Becton, Dickinson and Company, Kurve Technology Inc., Cook Medical, Medica Holdings, Integra LifeSciences, BVM Meditech Private Limited
North America is the fastest-growing region in the market
| 1. Executive Summary |
| 2. Global Mucosal Atomization Devices Market Introduction |
| 2.1. Global Mucosal Atomization Devices Market Taxonomy |
| 2.2. Global Mucosal Atomization Devices Market Definitions |
| 2.2.1. Type |
| 2.2.2. End User |
| 2.2.3. Geography |
| 3. Global Mucosal Atomization Devices Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Mucosal Atomization Devices Market Dynamic Factors - Impact Analysis |
| 3.6. Global Mucosal Atomization Devices Market Competition Landscape |
| 4. Global Mucosal Atomization Devices Market Analysis 2020 - 2024 and Forecast, 2025 - 2031 |
| 4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Mucosal Atomization Devices Market, By Type, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1. Gas Propulsion |
| 5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Electronic Atomizer |
| 5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Others |
| 5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6. Global Mucosal Atomization Devices Market Forecast, By End User, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 6.1. Hospitals |
| 6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Ambulatory Surgical Centers |
| 6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Specialists Clinic |
| 6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7. Global Mucosal Atomization Devices Market Forecast, By Region, 2020 - 2024 and Forecast, 2025 - 2031(Revenue, USD Mn) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia-Pacific |
| 7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Middle East and Africa |
| 7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Global Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Region, 2024 - 2030 |
| 8. North America Mucosal Atomization Devices Market Analysis,2020 - 2024 and Forecast, 2025 - 2031(Revenue, USD Mn) |
| 8.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1. Gas Propulsion |
| 8.1.2. Electronic Atomizer |
| 8.1.3. Others |
| 8.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 8.2.1. Hospitals |
| 8.2.2. Ambulatory Surgical Centres |
| 8.2.3. Specialists Clinic |
| 8.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 8.3.1. USA |
| 8.3.2. Canada |
| 8.4. North America Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Country, 2024 - 2030 |
| 8.5. North America Mucosal Atomization Devices Market Dynamics Trends |
| 9. Europe Mucosal Atomization Devices Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031(Revenue, USD Mn) |
| 9.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Gas Propulsion |
| 9.1.2. Electronic Atomizer |
| 9.1.3. Others |
| 9.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 9.2.1. Hospitals |
| 9.2.2. Ambulatory Surgical Centres |
| 9.2.3. Specialists Clinic |
| 9.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 9.3.1. Germany |
| 9.3.2. UK |
| 9.3.3. France |
| 9.3.4. Spain |
| 9.3.5. Italy |
| 9.3.6. Russia |
| 9.3.7. Poland |
| 9.3.8. Rest of Europe |
| 9.4. Europe Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Country, 2024 - 2030 |
| 9.5. Europe Mucosal Atomization Devices Market Dynamics Trends |
| 10. Asia-Pacific Mucosal Atomization Devices Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 10.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Gas Propulsion |
| 10.1.2. Electronic Atomizer |
| 10.1.3. Others |
| 10.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Hospitals |
| 10.2.2. Ambulatory Surgical Centres |
| 10.2.3. Specialists Clinic |
| 10.3. Country Analysis2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Japan |
| 10.3.2. China |
| 10.3.3. India |
| 10.3.4. ASEAN |
| 10.3.5. Australia & New Zealand |
| 10.3.6. Rest of Asia-Pacific |
| 10.4. Asia-Pacific Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Country,2024 - 2030 |
| 10.5. Asia-Pacific Mucosal Atomization Devices Market Dynamics Trends |
| 11. Latin America Mucosal Atomization Devices Market Analysis,2020 - 2024 and Forecast, 2025 - 2031(Revenue, USD Mn) |
| 11.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Gas Propulsion |
| 11.1.2. Electronic Atomizer |
| 11.1.3. Others |
| 11.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Hospitals |
| 11.2.2. Ambulatory Surgical Centres |
| 11.2.3. Specialists Clinic |
| 11.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Brazil |
| 11.3.2. Mexico |
| 11.3.3. Argentina |
| 11.3.4. Rest of Latin America |
| 11.4. Latin America Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Country, 2024 - 2030 |
| 11.5. Latin America Mucosal Atomization Devices Market Dynamics Trends |
| 12. Middle East and Africa Mucosal Atomization Devices Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031 (Revenue, USD Mn) |
| 12.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Gas Propulsion |
| 12.1.2. Electronic Atomizer |
| 12.1.3. Others |
| 12.2. End User Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Hospitals |
| 12.2.2. Ambulatory Surgical Centres |
| 12.2.3. Specialists Clinic |
| 12.3. Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Gulf Cooperation Council (GCC) Countries |
| 12.3.2. Israel |
| 12.3.3. South Africa |
| 12.3.4. Rest of MEA |
| 12.4. MEA Mucosal Atomization Devices Market - Opportunity Analysis Index, By Type, End User and Country, 2024 - 2030 |
| 12.5. MEA Mucosal Atomization Devices Market Dynamics Trends |
| 13. Competition Landscape |
| 13.1. Strategic Dashboard of Top Market Players |
| 13.2. Company Profiles (Introduction, Financial Analysis, Product Type& Service Testing Types, Key Developments, Strategies, and SWOT Analysis) |
| 13.2.1. Teleflex Incorporated |
| 13.2.2. DeVilbiss Healthcare LLC |
| 13.2.3. Becton, Dickinson and Company |
| 13.2.4. Kurve Technology Inc. |
| 13.2.5. Cook Medical |
| 13.2.6. Medica Holdings |
| 13.2.7. Integra LifeSciences |
| 13.2.8. BVM Meditech Private Limited |
| 14. Research Methodology |
| 15. Key Assumptions and Acronyms |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.